Selected News & Events
Stealth BioTherapeutics to Present Overview of Elamipretide Clinical Development Program in Barth Syndrome at the 2023 American College of Medical Genetics Meeting
Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Stealth BioTherapeutics to Participate in Upcoming Ultra-Rare Disease Events
Stealth BioTherapeutics Granted Pre-NDA Meeting for Elamipretide as a Potential Treatment for Barth Syndrome
Events Calendar
No events listed at this time.
@StealthBT on Twitter
Contact Us
Stealth BioTherapeutics
275 Grove Street, Suite 3-107
Newton, MA 02466
(617) 600-6888
info@stealthbt.com